← Eichor
Condition: Pneumocystis Jirovecii Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pneumocystis Jirovecii Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Phase N/A · 1 location(s) · Instituto Nacional de Enfermedades Respiratorias · NCT06691321Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammat
Phase 4 · 1 location(s) · Tongji Hospital · NCT06499233Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults
Phase 2 · 6 location(s) · Mundipharma Research Limited · NCT05835479Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT07681583Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
Phase 3 · 1 location(s) · Todd C. Lee MD MPH FIDSA · NCT04851015
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.